Spyre Therapeutics, Inc. (SYRE)
NASDAQ·Healthcare·Biotechnology
$99.26
+0.21%
Mkt Cap $8.34B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (30 analysts)
$111.82
Range $80.00 – $130.00
Implied Upside
+12.7%
Consensus $111.82 vs current $99.26
NASDAQ·Healthcare·Biotechnology
$99.26
+0.21%
Mkt Cap $8.34B
Buy
17
Hold
0
Sell
0
Price Target (30 analysts)
$111.82
Range $80.00 – $130.00
+12.7%
Consensus $111.82 vs current $99.26